首页 | 本学科首页   官方微博 | 高级检索  
检索        

卡培他滨加顺铂治疗晚期胃肠道肿瘤的临床观察
引用本文:陈阵,王哲海,郑应馨,刘波.卡培他滨加顺铂治疗晚期胃肠道肿瘤的临床观察[J].中国肿瘤临床与康复,2004,11(3):242-243.
作者姓名:陈阵  王哲海  郑应馨  刘波
作者单位:山东省肿瘤医院内科,济南,250117
摘    要:目的观察卡培他滨与顺铂合用治疗晚期消化道肿瘤的近期疗效.方法卡培他滨1300 mg/(m2*d),分2~3次口服,连服14 d;PDD 20 mg/次,静滴,第1~5天(或40 mg/次,静滴,第1~3天);21 d为1周期,连用2或3周期.结果可评价者35例,PR 12例,总有效率为34.3%.毒副反应主要是骨髓抑制和消化道反应.结论卡培他滨 顺铂治疗晚期消化道肿瘤可获得较高疗效,毒副反应轻,是一种较好的联合化疗方案.

关 键 词:胃肠肿瘤/化学疗法  卡培他滨  顺铂
文章编号:1005-8664(2004)03-0242-02
修稿时间:2003年9月20日

Clinical observation of capecitabine and PDD for treatment of advanced gastrointestinal cancer
CHEN Zhen,WANG Zhe-hai,ZHEN Ying-xin,et al.Clinical observation of capecitabine and PDD for treatment of advanced gastrointestinal cancer[J].Chinese Journal of Clinical Oncology and Rehabilitation,2004,11(3):242-243.
Authors:CHEN Zhen  WANG Zhe-hai  ZHEN Ying-xin  
Abstract:Objective To evaluate the ef ficacy of combined chemotherapy with capec itabine and cisplatin(PDD) in the treatment of advanced gastrointestinal cancer .Method From June 2001 to May 2003,37 patien ts with advanced gastrointestinal cancer received oral capecitabine 1300 mg/m2,d1-14 and PDD 20 mg,introvenou s dri p (ID) d1-5 or 40 mg ID d1-3.The regimen was repeated every 3 weeks and each p atient received 2 or 3 cycles at least.Results Thi rty-five patients were evaluable for efficacy.12 PR occurred and the overall response rate was 34.3%.The dose-lim i ted toxicity was leukocytopenia and other side effects were mild. Conclusion Capeci tabine combined with cisplatin is an effective regimen for advanced gastrointest inal cancer.The side effects are mild and tolerable.
Keywords:Gastrointestinal neoplasm/che motherapy  Capecitabine  Cisplatin
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号